Implications of continued response after autologous stem cell transplantation for multiple myeloma

Patients undergoing autologous stem cell transplantation (ASCT) for multiple myeloma (MM) undergo disease assessment approximately 100 days later. Some patients continue to have a decline in their serum or urine monoclonal protein after day 100 in the absence of additional therapy. We evaluated 430...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gonsalves, Wilson I., Gertz, Morie A., Dispenzieri, Angela, Lacy, Martha Q., Lin, Yi, Singh, Preet P., Gupta, Vinay, Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Kapoor, Prashant, McCurdy, Arleigh R., Kumar, Shaji K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2013
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765057/
https://ncbi.nlm.nih.gov/pubmed/23863899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-492678
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados